DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Tubach F, Salmon D, Ravaud P. et al
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. 
Arthritis and Rheumatism 2009; 60: 1884-1894  

Download Bibliographical Data

Search in: